ALPHA TAU MEDICAL LTD.

Analyst Reco. Alpha Tau Medical Ltd.

Equities

DRTS

IL0011839383

Market Closed - Nasdaq Other stock markets 04:30:00 2024-07-05 pm EDT			5-day change	1st Jan Change
2.21 ^USD	-0.90%		-12.65%	-26.58%

Jun. 25	Alpha Tau Medical Ltd. Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-To-Treat Superficial Cancers	CI
May. 20	Alpha Tau Medical Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Piper Sandler Adjusts Alpha Tau Medical's Price Target to $8 From $12, Keeps Overweight Rating	Nov. 17	MT
HC Wainwright Starts Alpha Tau Medical at Buy With $9 Price Target	23-04-24	MT
Piper Sandler Adjusts Alpha Tau Medical's Price Target to $12 From $19, Keeps Overweight Rating	22-11-23	MT
Cantor Fitzgerald Initiates Alpha Tau Medical at Overweight with $20 Price Target	22-04-14	MT
Piper Sandler Starts Alpha Tau Medical at Overweight With $19 Price Target	22-04-08	MT
Citigroup Initiates Alpha Tau Medical at Buy With $21 Price Target	22-04-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer